Overview
Jingjing Liu practices practicing medicine in Beijing, China.
Their clinical expertise encompasses Ebola Virus Disease, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Viral Hemorrhagic Fever.
They are actively involved in clinical research, co-authoring 17 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jingjing Liu
Is Jingjing Liu a top-rated expert for Ebola Virus Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Jingjing Liu is classified as an Experienced expert for Ebola Virus Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jingjing Liu participate in research or clinical trials?
Yes. Jingjing Liu has published 17 articles and abstracts on conditions like Ebola Virus Disease. You can view a list of Jingjing Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Liu isExperienced. Learn about COVID-19.
- Ebola Virus DiseaseLiu isExperienced. Learn about Ebola Virus Disease.
- Severe Acute Respiratory Syndrome (SARS)
- Viral Hemorrhagic FeverLiu isExperienced. Learn about Viral Hemorrhagic Fever.